For: | Bonacini M, Kassamali F, Kari S, Lopez Barrera N, Kohla M. Racial differences in prevalence and severity of non-alcoholic fatty liver disease. World J Hepatol 2021; 13(7): 763-773 [PMID: 34367497 DOI: 10.4254/wjh.v13.i7.763] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i7/763.htm |
Number | Citing Articles |
1 |
Huilian Shi, Fei Qiao, Kaiyue Huang, Weiting Lu, Xinzhuang Zhang, Zhipeng Ke, Yanchi Wu, Liang Cao, Yuanyuan Chen. Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation. Journal of Ethnopharmacology 2022; 296: 115477 doi: 10.1016/j.jep.2022.115477
|
2 |
Naveeda Nawaz, Saba Arif, Rehan Anwar, Adnan Riaz, Asima Ayyub, Rafia Javed. Association of Adiponectin and Oxidized HDL with ABO Blood Groups in Fatty Liver Patients. Pakistan Journal of Health Sciences 2024; : 79 doi: 10.54393/pjhs.v5i07.1847
|
3 |
Jasmin de Groot, Susana Santos, Madelon L. Geurtsen, Janine F. Felix, Vincent W.V. Jaddoe. Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood. eClinicalMedicine 2023; 65: 102248 doi: 10.1016/j.eclinm.2023.102248
|
4 |
Rebeca Garazi Elguezabal Rodelo, Leonardo M. Porchia, Enrique Torres‐Rasgado, Esther López-Bayghen, M. Elba Gonzalez-Mejia, Matias A Avila. Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome’s effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017–2018. PLOS ONE 2024; 19(2): e0298662 doi: 10.1371/journal.pone.0298662
|
5 |
Banrida Wahlang, Hong Gao, Shesh N. Rai, Rachel J. Keith, Craig J. McClain, Sanjay Srivastava, Mathew C. Cave, Aruni Bhatnagar. Associations between residential volatile organic compound exposures and liver injury markers: The role of biological sex and race. Environmental Research 2023; 221: 115228 doi: 10.1016/j.envres.2023.115228
|
6 |
Yi-Jie Li, Brittney O Baumert, Nikos Stratakis, Jesse A Goodrich, Hao-Tian Wu, Jing-Xuan He, Yin-Qi Zhao, Max T Aung, Hong-Xu Wang, Sandrah P Eckel, Douglas I Walker, Damaskini Valvi, Michele A La Merrill, Justin R Ryder, Thomas H Inge, Todd Jenkins, Stephanie Sisley, Rohit Kohli, Stavra A Xanthakos, Andrea A Baccarelli, Rob McConnell, David V Conti, Lida Chatzi. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
Abstract(245) |
Core Tip(274) |
Full Article(HTML)(1818)
|
Full Article with Cover (PDF)-1817K(50)
|
Full Article (Word)-765K(11)
|
Audio-1282K(8)
|
Peer-Review Report-233K(33)
|
Answering Reviewers-203K(32)
|
Supplementary Material-59K(42)
|
Full Article (PDF)-1390K(104)
|
Full Article (XML)-191K(28)
|
Times Cited (0)
|
Total Visits (3900)
|
Open
|
7 |
Ling Yang, Hangkai Huang, Zhening Liu, Jiaqi Ruan, Chengfu Xu. Association of the android to gynoid fat ratio with nonalcoholic fatty liver disease: a cross-sectional study. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1162079
|
8 |
Mohamed I. Elsaid, John F. P. Bridges, Khalid Mumtaz, Na Li, Lindsay Sobotka, Vinod K. Rustgi, Electra D. Paskett, Vikramaditya Samala Venkata. The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease. PLOS ONE 2024; 19(3): e0299836 doi: 10.1371/journal.pone.0299836
|
9 |
Somtochukwu Stephen Onwuzo, Asif Ali Hitawala, Antoine Boustany, Prabhat Kumar, Ashraf Almomani, Chidera Onwuzo, Jessy Mascarenhas Monteiro, Imad Asaad. Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study. World Journal of Hepatology 2023; 15(2): 265-273 doi: 10.4254/wjh.v15.i2.265
|
10 |
Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W. Timothy Garvey, Sangeeta Kashyap, Jeffrey I. Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E. Rinella, Miriam B. Vos, Zobair Younossi. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings. Endocrine Practice 2022; 28(5): 528 doi: 10.1016/j.eprac.2022.03.010
|
11 |
Marlen Ivon Castellanos-Fernandez, Shreya C. Pal, Marco Arrese, Juan Pablo Arab, Jacob George, Nahum Méndez-Sánchez. Nonalcoholic Fatty Liver Disease in Latin America and Australia. Clinics in Liver Disease 2023; 27(2): 301 doi: 10.1016/j.cld.2023.01.015
|
12 |
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients 2022; 14(21): 4556 doi: 10.3390/nu14214556
|
13 |
Yasuyuki Komiyama, Utaroh Motosugi, Shinya Maekawa, Leona Osawa, Natsuko Nakakuki, Hitomi Takada, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Shinichi Takano, Mitsuharu Fukasawa, Tatsuya Yamaguchi, Hiroshi Onishi, Meng Yin, Nobuyuki Enomoto. Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography. Hepatology Research 2023; 53(3): 208 doi: 10.1111/hepr.13858
|
14 |
Chuwei Yu, Jing Chen, Jin Ren. Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment. Molecular Biology Reports 2022; 49(10): 9841 doi: 10.1007/s11033-022-07503-0
|
15 |
Eftitan Y. Akam, Akua A. Nuako, Afkera K. Daniel, Fatima Cody Stanford. Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention. Current Diabetes Reports 2022; 22(3): 129 doi: 10.1007/s11892-022-01451-6
|
16 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
|